Pink Sheet Podcast: Aduhelm Label Change, First Half Drug Approvals, FTC Investigative Power

Pink Sheet reporters and editors discuss the implications of Aduhelm’s updated indication, CDER’s new drug approvals in the first half of 2021, and an FTC policy change that will make investigating pharma easier.